Published in J Natl Cancer Inst on August 02, 1995
Parental cancer and risk of papillary and follicular thyroid carcinoma. Br J Cancer (1997) 0.86
Design and serendipity in establishing a large cohort with wide dietary intake distributions : the National Institutes of Health-American Association of Retired Persons Diet and Health Study. Am J Epidemiol (2001) 11.17
Beta-D-fructofuranoside fructohydrolase from yeast. Methods Enzymol (1975) 9.19
Breast cancer clusters in the northeast United States: a geographic analysis. Am J Epidemiol (1997) 5.73
Tables of the number of patients required in clinical trials using the logrank test. Stat Med (1983) 5.34
Allocation of patients to treatment groups in a controlled clinical study. Br J Cancer (1978) 5.25
On the use of Pocock and Simon's method for balancing treatment numbers over prognostic factors in the controlled clinical trial. Biometrics (1976) 3.82
Dynorphin is a specific endogenous ligand of the kappa opioid receptor. Science (1982) 3.80
Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res (1978) 3.51
Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance. J Natl Cancer Inst (1996) 2.98
Morphine-tolerant longitudinal muscle strip from guinea-pig ileum. Br J Pharmacol (1973) 2.93
Stereospecific and nonspecific interactions of the morphine congener levorphanol in subcellular fractions of mouse brain. Proc Natl Acad Sci U S A (1971) 2.82
Dynorphin-(1-13), an extraordinarily potent opioid peptide. Proc Natl Acad Sci U S A (1979) 2.66
Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer (1999) 2.66
Specific receptor for the opioid peptide dynorphin: structure--activity relationships. Proc Natl Acad Sci U S A (1981) 2.53
Implications of a new dietary measurement error model for estimation of relative risk: application to four calibration studies. Am J Epidemiol (1999) 2.40
A peptide-like substance from pituitary that acts like morphine. 2. Purification and properties. Life Sci (1975) 2.34
Empirical evidence of correlated biases in dietary assessment instruments and its implications. Am J Epidemiol (2001) 2.33
Injuries sustained on "bouncy castles". BMJ (1992) 2.20
Opioid activity of a peptide, beta-lipotropin-(61-91), derived from beta-lipotropin. Proc Natl Acad Sci U S A (1976) 2.16
Forced expiratory flows and volumes in infants. Normative data and lung growth. Am J Respir Crit Care Med (2000) 1.95
Histological grade and other prognostic factors in relation to survival of patients with breast cancer. Br J Cancer (1979) 1.92
The CHART trials: Bayesian design and monitoring in practice. CHART Steering Committee. Stat Med (1994) 1.90
Potential impact of genetic testing on cancer prevention trials, using breast cancer as an example. J Natl Cancer Inst (1995) 1.84
A predictive approach to selecting the size of a clinical trial, based on subjective clinical opinion. Stat Med (1986) 1.82
Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone. Lancet (1987) 1.79
Opioid peptides and opioid receptors in cells of the immune system. Annu Rev Immunol (1988) 1.76
Porcine pituitary dynorphin: complete amino acid sequence of the biologically active heptadecapeptide. Proc Natl Acad Sci U S A (1981) 1.74
Tolerance to opioid narcotics. I. Tolerance to the "running fit" caused by levorphanol in the mouse. J Pharmacol Exp Ther (1969) 1.73
Psychotropic effects of caffeine in man. IV. Quantitative and qualitative differences associated with habituation to coffee. Clin Pharmacol Ther (1969) 1.72
A specific radioimmunoassay for the novel opioid peptide dynorphin. Life Sci (1980) 1.67
The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: a further report with 7 years of follow up. J Urol (1996) 1.63
Interpreting precursor studies: what polyp trials tell us about large-bowel cancer. J Natl Cancer Inst (1994) 1.61
Can energy adjustment separate the effects of energy from those of specific macronutrients? Am J Epidemiol (1994) 1.56
Limited capacity for protein synthesis at zero degrees centigrade in Escherichia coli. J Mol Biol (1968) 1.51
Increased urinary nitrite excretion in children with minimal change nephrotic syndrome. J Pediatr (1996) 1.51
Opioid peptides endorphins in pituitary and brain. Science (1976) 1.50
Relationship among outcome, stage of disease, and histologic grade for 22,616 cases of breast cancer. The basis for a prognostic index. Cancer (1991) 1.49
The use of a Kolmogorov--Smirnov type statistic in testing hypotheses about seasonal variation. J Epidemiol Community Health (1979) 1.49
Cloning and pharmacological characterization of a rat kappa opioid receptor. Proc Natl Acad Sci U S A (1993) 1.47
Primary care physicians' views on access and health care reform: the situation in North Carolina. J Fam Pract (1993) 1.46
Lymphoid apoptosis and myeloid hyperplasia in CCAAT displacement protein mutant mice. Blood (2001) 1.45
Imaging of pelvic postpartum complications. AJR Am J Roentgenol (1997) 1.44
A peptide-like substance from pituitary that acts like morphine. I. Isolation. Life Sci (1975) 1.44
Inhibition by chlorampenicol of the growth of nascent protein chains in Escherichia coli. Mol Pharmacol (1966) 1.43
Bayesian monitoring of phase II trials in cancer chemoprevention. J Clin Epidemiol (1999) 1.41
Sequence and expression of the rat prodynorphin gene. Proc Natl Acad Sci U S A (1985) 1.40
A stratified Wilcoxon-type test for trend. Stat Med (1990) 1.40
The future of prognostic factors in outcome prediction for patients with cancer. Cancer (1992) 1.39
Effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: interim report from the Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party). Br Med J (Clin Res Ed) (1988) 1.39
Transcranial sonography through the burr hole for detection of ventriculomegaly. A preliminary report. J Ultrasound Med (1991) 1.39
Fermi observations of high-energy gamma-ray emission from GRB 080916C. Science (2009) 1.37
Ligand dissociation constants from competition binding assays: errors associated with ligand depletion. Mol Pharmacol (1987) 1.36
Stopping rules for clinical trials incorporating clinical opinion. Biometrics (1984) 1.33
Immunoreactive dynorphin in pituitary and brain. Proc Natl Acad Sci U S A (1980) 1.33
Effect of starvation on the tissue composition of the small intestine in the rat. Am J Physiol (1968) 1.31
Demonstration of a specific dynorphin receptor in guinea pig ileum myenteric plexus. Nature (1981) 1.30
ZONE BEHAVIOR OF ENZYMES : ILLUSTRATED BY THE EFFECT OF DISSOCIATION CONSTANT AND DILUTION ON THE SYSTEM CHOLINESTERASE-PHYSOSTIGMINE. J Gen Physiol (1943) 1.29
Variations in the level of reporting by hospitals to a regional cancer registry. Br J Cancer (1978) 1.29
Randomised comparative studies in the treatment of cancer in the United Kingdom: room for improvement? Lancet (1979) 1.29
Early open reduction and internal fixation of the disrupted pelvic ring. J Trauma (1986) 1.29
Randomized, placebo-controlled, double-blind study of low-dose oral interferon-alpha in HIV-1 antibody positive patients. J Acquir Immune Defic Syndr (1992) 1.27
An assay for dopamine-beta-hydroxylase activity in tissues and serum. Experientia (1971) 1.26
Morphine and other opiates from beef brain and adrenal. Proc Natl Acad Sci U S A (1985) 1.26
Site-directed alkylation of multiple opioid receptors. I. Binding selectivity. Mol Pharmacol (1984) 1.25
Tolerance to opioid narcotics: time course and reversibility of physical dependence in mice. Nature (1971) 1.24
Adult thymectomy prevention of the appearance of suppressor T cells which depress contact sensitivity to picryl chloride and reversal of adult thymectomy effect by thymus extract. Eur J Immunol (1976) 1.22
Cux/CDP homeoprotein is a component of NF-muNR and represses the immunoglobulin heavy chain intronic enhancer by antagonizing the bright transcription activator. Mol Cell Biol (1999) 1.21
Stereospecific nicotine receptors on rat brain membranes. Science (1980) 1.21
Training the indigenous nonprofessional: the screening technician. J Pediatr (1970) 1.21
Dynorphin immunocytochemical localization in brain and peripheral nervous system: preliminary studies. Proc Natl Acad Sci U S A (1981) 1.19
Multivariate analysis of prognostic factors for operable rectal cancer. Lancet (1984) 1.18
Chronic granulomatous disease presenting in childhood with Pseudomonas cepacia septicaemia. J Infect (1993) 1.16
Training pediatric residents to prevent tobacco use. Pediatrics (1995) 1.16
Nicotine self-administration in rats. Br J Pharmacol (1984) 1.16
The polyp prevention trial I: rationale, design, recruitment, and baseline participant characteristics. Cancer Epidemiol Biomarkers Prev (1996) 1.15
Monitoring clinical trials: conditional or predictive power? Control Clin Trials (1986) 1.14
An analysis of 161 falls from a height: the 'jumper syndrome'. J Trauma (1986) 1.14
Recovery from vaginal hysterectomy compared with laparoscopy-assisted vaginal hysterectomy: a prospective, randomized, multicenter study. Acta Obstet Gynecol Scand (2001) 1.14
Isolation and amino acid sequence analysis of a 4,000-dalton dynorphin from porcine pituitary. Proc Natl Acad Sci U S A (1982) 1.14
Interplay between design and analysis for behavioral intervention trials with community as the unit of randomization. Am J Epidemiol (1995) 1.13
The use of minoxidil to attempt to prevent alopecia during chemotherapy for gynecologic malignancies. Eur J Gynaecol Oncol (1991) 1.13
Psychotropic effects of caffeine in man. 3. A questionnaire survey of coffee drinking and its effects in a group of housewives. Clin Pharmacol Ther (1969) 1.13
The incidence, prevalence, and severity of sarcoidosis in New York City firefighters. Chest (1999) 1.13
A twofold increase in BRCA mutation related prostate cancer among Ashkenazi Israelis is not associated with distinctive histopathology. J Med Genet (2003) 1.13
Examining alcohol outcome expectancies in laboratory and naturalistic bar settings: a within-subject experimental analysis. Psychol Addict Behav (2001) 1.12
A synthetic peptide with morphine-like pharmacologic action. Life Sci (1975) 1.12
Effect of different types and amounts of fat on the development of mammary tumors in rodents: a review. Cancer Res (1997) 1.11
Opioid receptor reserve in normal and morphine-tolerant guinea pig ileum myenteric plexus. Proc Natl Acad Sci U S A (1984) 1.11
Comparison of the distribution of dynorphin systems and enkephalin systems in brain. Science (1982) 1.11
An overview of published results from randomized studies of nitrosoureas in primary high grade malignant glioma. Br J Cancer (1987) 1.10
Expression cloning of cDNA encoding a seven-helix receptor from human placenta with affinity for opioid ligands. Proc Natl Acad Sci U S A (1992) 1.10
Dynorphin is contained within hippocampal mossy fibers: immunochemical alterations after kainic acid administration and colchicine-induced neurotoxicity. Proc Natl Acad Sci U S A (1983) 1.09
System delay in breast cancer in whites and blacks. Am J Epidemiol (1995) 1.09
Heroin addiction and the role of methadone in its treatment. Arch Gen Psychiatry (1972) 1.09
A pituitary endorphin with novel properties. Life Sci (1979) 1.09
Morphine and codeine from mammalian brain. Proc Natl Acad Sci U S A (1986) 1.08
Dynorphin and vasopressin: common localization in magnocellular neurons. Science (1982) 1.08
The use of the multiplicity survey to identify migrants. Demography (1981) 1.08